Integrin αIIbβ3

Platelets

Volumn , Issue , 2013, Pages 233-248

  Bledzka, Kamila ^a   Pesho, Michelle M ^a   Ma, Yan Qing ^a   Plow, Edward F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882611775     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-387837-3.00012-2     Document Type: Chapter

References (269)

1. Adams P.C., Badimon J.J., Badimon L., Chesebro J.H., Fuster V. Role of platelets in atherogenesis: relevance to coronary arterial restenosis after angioplasty. Cardiovasc Clin 1987, 18:49-71.
2. Ross R. Atherosclerosis: a defense mechanism gone awry. Am. J. Pathol 1993, 143:987-1002.
3. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995, 91:2844-2850.
4. Nurden A.T. Platelets, inflammation and tissue regeneration. Thromb. Haemost 2011, 105(Suppl. 1):S13-S33.
5. Bennett J.S. The molecular biology of platelet membrane proteins. Semin. Hematol 1990, 27:186-204.
6. Plow E.F., Byzova T. The biology of glycoprotein IIb-IIIa. Coron Artery Dis 1999, 10:547-551.
7. Plow E.F., D'Souza S.E., Ginsberg M.H. Ligand binding to GPIIb-IIIa: a status report. Semin Thromb Hemost 1992, 18:324-332.
8. Savage B., Cattaneo M., Ruggeri Z.M. Mechanisms of platelet aggregation. Curr Opin Hematol 2001, 8:270-276.
9. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
10. Plow E.F., Haas T.A., Zhang L., Loftus J., Smith J.W. Ligand binding to integrins. J Biol Chem 2000, 275:21785-21788.
11. Plow E.F., Shattil S.J. Integrin αIIbβ3 and platelet aggregation. Hemostasis and Thrombosis: Basic Principles and Clinical Practice 2001, 479-491. Lippincott, Williams & Wilkins, Philadelphia. R.W. Colman, J. Hirsh, V.J. Marder, A.W. Clowes, J.N. George (Eds.).
12. Reheman A., Gross P., Yang H., Chen P., Leytin V., et al. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost 2005, 3:875-883.
13. Plow E.F., Marguerie G.A. Inhibition of fibrinogen binding to human platelets by the tetrapeptide Glycyl-L-Prolyl-L-Arginyl-L-Proline. Proc Natl Acad Sci USA 1982, 79:3711-3715.
14. Coller B.S., Peerschke E.I., Scudder L.E., Sullivan C.A. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J. Clin. Invest 1983, 72:325-338.
15. Bhatt D.L., Topol E.J. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. J Am Med Assoc 2000, 284:1549-1558.
16. Lischke S., Schneider D.J. Recent developments in the use of antiplatelet agents to prevent cardiovascular events. Future Cardiol 2011, 7:403-413.
17. Hynes R.O. Integrins: Bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
18. Ruoslahti E., Engvall E. Perspectives Series: cell adhesion in vascular biology. Integrins and vascular extracellular matrix assembly. J Clin Invest 1997, 99:1149-1152.
19. Beer A.J., Schwaiger M. Imaging of integrin alphavbeta3 expression. Cancer Metastasis Rev 2008, 27:631-644.
20. 3-integrins. J Biol Chem 1994, 269:960-967.
21. Lam S.C., Plow E.F., D'Souza S.E., Cheresh DA, Frelinger III AL, Ginsberg MH Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. J Biol Chem 1989, 264:3742-3749.
22. Lawler J., Hynes R.O. An integrin receptor on normal and thrombasthenic platelets that bind thrombospondin. Blood 1989, 74:2022-2027.
23. Uzan G., Prenant M., Prandini M.-H., Martin F., Marguerie G. Tissue-specific expression of the platelet GPIIb gene. J Biol Chem 1991, 266(14):8932-8939.
24. 3 integrin. Cancer Res 1996, 56:5071-5078.
25. Butler-Zimrin A.E., Bennett J.S., Poncz M., Schwartz E., Surrey S., Esman R., et al. Isolation and characterization of cDNA clones for the platelet membrane glycoproteins IIb and IIIa. Thromb Haemost 1987, 58:319a.
26. Emambokus N.R., Frampton J. The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis. Immunity 2003, 19:33-45.
27. Oki T, Kitaura J, Eto K, Lu Y, Maeda-Yamamoto M, Inagaki N, et al. Integrin alphaIIbbeta3 induces the adhesion and activation of mast cells through interaction with fibrinogen. J Immunol 2006, 176:52-60.
28. Oki T., Eto K., Izawa K., Yamanishi Y, Inagaki N, Frampton J, et al. Evidence that integrin alpha IIb beta 3-dependent interaction of mast cells with fibrinogen exacerbates chronic inflammation. J. Biol. Chem 2009, 284:31463-31472.
29. Sheldrake H.M., Patterson L.H. Function and antagonism of beta3 integrins in the development of cancer therapy. Curr Cancer Drug Targets 2009, 9:519-540.
30. Cheresh D.A. Structural and biologic properties of integrin-mediated cell adhesion. Clinics in Laboratory Medicine 1992, 12:217.
31. 3 in vascular biology. Thromb Haemost 1998, 80:726-734.
32. Varner J.A., Brooks P.C., Cheresh D.A. Review: the integrin alpha V beta 3: angiogenesis and apoptosis. Cell Adhes Commun 1995, 3:367-374.
33. Phillips D.R., Charo I.F., Parise L.V., Fitzgerald L.A. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988, 71:831-843.
34. Niiya K., Hodson E., Bader R., Byers-Ward V, Koziol JA, Plow EF, et al. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood 1987, 70:475-483.
35. Wagner C.L., Mascelli M.A., Neblock D.S., Weisman HF, Coller BS, Jordan RE Analysis of GPIIb/IIIa receptor number by quanitification of 7E3 binding to human platelets. Blood 1996, 88:907-914.
36. Stouffer G.A., Smyth S.S. Effects of thrombin on interactions between beta3-integrins and extracellular matrix in platelets and vascular cells. Arterioscler Thromb Vasc Biol 2003, 23:1971-1978.
37. Wencel-Drake J.D., Plow E.F., Kunicki T.J., Woods VL, Keller DM, Ginsberg MH Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses. Am J Pathol 1986, 124:324-334.
38. Woods V.L. Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins. J Biol Chem 1986, 261:15242-15251.
39. Fujimura K., Phillips D.R. Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes. J Biol Chem 1983, 258:10247-10252.
40. Sosnoski D.M., Emanuel B.S., Hawkins A.L., van Tuinen P, Ledbetter DH, Nussbaum RL, et al. Chromosomal localization of the genes for the vitronectin and fibronectin receptors α subunits and for platelet glycoproteins IIb and IIIa. J Clin Invest 1988, 81:1993-1998.
41. Duperray A., Berthier R., Chagnon E., Ryckwaert J-J, Ginsberg M, Plow E, et al. Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes. J. Cell Biol 1987, 104:1665-1673.
42. Loftus J.C., Plow E.F., Jennings L.K., Ginsberg M.H. Alternative proteolytic processing of platelet membrane GPIIb. J Biol Chem 1988, 263:11025-11028.
43. Poncz M., Eisman R., Heidenreich R., Silver SM, Vilaire G, Surrey S, et al. Structure of the platelet membrane glycoprotein IIb. Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors. J Biol Chem 1987, 262:8476-8482.
44. Zimrin A.B., Gidwitz S., Lord S., Schwartz E, Bennett JS, White II GC, et al. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 1990, 265:8590-8595.
45. Fitzgerald L.A., Steiner B., Rall S.C.J., Lo S.S., Phillips D.R. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin.". J Biol Chem 1987, 262:3936-3939.
46. Xiong J.P., Stehle T., Diefenbach B., Zhang R, Dunker R, Scott DL, et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 2001, 294:339-345.
47. Xiao T., Takagi J., Coller B.S., Wang J.H., Springer T.A. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004, 432:59-67.
48. Zhu J., Luo B.H., Xiao T., et al. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell 2008, 32:849-861.
49. Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 2002, 296:151-155.
50. Xiong J.P., Mahalingham B., Alonso J.L., Borrelli L.A., Rui X., Anand S., et al. Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment. J Cell Biol 2009, 186:589-600.
51. Springer T.A. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain. Proc Natl Acad. Sci. USA 1997, 94:65-72.
52. Springer T.A. Predicted and experimental structures of integrins and β-propellers. Curr Opin Struct Biol 2002, 12:802-813.
53. Humphries M.J., Symonds E.J., Mould A.P. Mapping functional residues onto integrin crystal structures. Curr Opin Struct Biol 2003, 13:236-243.
54. Ma Y.Q., Qin J., Plow E.F. Platelet integrin alpha(IIb)beta(3): activation mechanisms. J Thromb Haemost 2007, 5:1345-1352.
55. Campbell I.D., Humphries M.J. Integrin structure, activation, and interactions. Cold Spring Harb. Perspect. Biol 2011, 3.
56. Kamata T, Handa M, Sato Y, Ikeda Y, Aiso S. Membrane-proximal {alpha}/{beta} stalk interactions differentially regulate integrin activation. J Biol Chem 2005, 280:24775-24783.
57. Xiong J.P., Stehle T., Goodman S.L., Arnaout M.A. Integrins, cations and ligands: making the connection. J Thromb Haemost 2003, 7:1642-1654.
58. Chothia C., Jones E.Y. The molecular structure of cell adhesion molecules. Annu Rev Biochem 1997, 66:823-862.
59. Beglova N., Blacklow S.C., Takagi J., Springer T.A. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol 2002, 9:282-287.
60. Takagi J., Petre B.M., Walz T., Springer T.A. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002, 110:599-611.
61. Luo B.H., Carman C.V., Springer T.A. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007, 25:619-647.
62. Calvete J.J., Henschen A., Gonzalez-Rodriguez J. Complete localization of the intrachain disulphide bonds and the N-glycosylation points in the alpha-subunit of human platelet glycoprotein IIb. Biochem J 1989, 261:561-568.
63. Humphries M.J. Integrin structure. Biochem Soc Trans 2000, 28:311-340.
64. Carrell N.A., Fitzgerald L.A., Steiner B., Erickson H.P., Phillips D.R. Structure of human platelet membrane glycoproteins IIb and IIIa as determined by electron microscopy. J Biol Chem 1985, 260:1743-1749.
65. Weisel J.W., Nagaswami C., Vilaire G., Bennett J.S. Examination of the platelet membrane GPIIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. J Biol Chem 1992, 267:16637-16643.
66. Adair B.D., Yeager M. Three-dimensional model of the human platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and X-ray crystallography. Proc Natl Acad Sci USA 2002, 99:14059-14064.
67. Gottschalk K.E. A coiled-coil structure of the alphaIIbbeta3 integrin transmembrane and cytoplasmic domains in its resting state. Structure 2005, 13:703-712.
68. Metcalf D.G., Kulp D.W., Bennett J.S., DeGrado W.F. Multiple approaches converge on the structure of the integrin alphaIIb/beta3 transmembrane heterodimer. J Mol Biol 2009, 392:1087-1101.
69. Wang W., Luo B.H. Structural basis of integrin transmembrane activation. J Cell Biochem 2009, 109:447-452.
70. Luo B.H., Springer T.A., Takagi J. A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol 2004, 2:776-786.
71. Luo B.H., Carman C.V., Takagi J., Springer T.A. Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc Natl Acad Sci USA 2005, 102:3679-3684.
72. Partridge A.W., Liu S., Kim S., Bowie J.U., Ginsberg M.H. Transmembrane domain helix packing stabilizes integrin alphaIIbbeta3 in the low affinity state. J Biol Chem 2005, 280:7294-7300.
73. Li R., Babu C.R., Lear J.D., Wand AJ, Bennett JS, DeGrado WF Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains. Proc Natl Acad Sci USA 2001, 98:12462-12467.
74. Li R., Mitra N., Gratkowski H., Vilaire G, Litvinov R, Nagasami C, et al. Activation of integrin αIIbβ3 by modulation of transmembrane helix associations. Science 2003, 300:795-798.
75. Li R., Gorelik R., Nanda V., Law PB, Lear JD, DeGrado WF, et al. Dimerization of the transmembrane domain of integrin alphaIIb subunit in cell membranes. J Biol Chem 2004, 279:26666-26673.
76. Li W., Metcalf D.G., Gorelik R., Li R, Mitra N, Nanda V, et al. A push-pull mechanism for regulating integrin function. Proc Natl Acad Sci USA 2005, 102:1424-1429.
77. Zhu H., Metcalf D.G., Streu C.N., Billings PC, DeGrado WF, Bennett JS Specificity for homooligomer versus heterooligomer formation in integrin transmembrane helices. J Mol Biol 2010, 401:882-891.
78. Yang J., Ma Y.Q., Page R.C., Misra S, Plow EF, Qin J Structure of an integrin alphaIIb beta3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation. Proc Natl Acad Sci USA 2009, 106:17729-17734.
79. Lau T.L., Kim C., Ginsberg M.H., Ulmer T.S. The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J 2009, 28:1351-1361.
80. Zhu J., Luo B.H., Barth P., Schonbrun J, Baker D, Springer TA The structure of a receptor with two associating transmembrane domains on the cell surface: integrin alphaIIbbeta3. Mol Cell 2009, 34:234-249.
81. Liu S.C., Calderwood D.A., Ginsberg M.H. Integrin cytoplasmic domain-binding proteins. J Cell Sci 2000, 113:3563-3571.
82. Aylward K., Meade G., Ahrens I., Devocelle M., Moran N. A novel functional role for the highly conserved alpha-subunit KVGFFKR motif distinct from integrin alphaIIbbeta3 activation processes. J Thromb Haemost 2006, 4:1804-1812.
83. Vinogradova O., Haas T., Plow E.F., Qin J. A structural basis for integrin activation by the cytoplasmic tail of the alpha IIb-subunit. Proc Natl Acad Sci USA 2000, 97:1450-1455.
84. Vinogradova O., Velyvis A., Velyviene A., Hu B, Haas TA, Plow EF, et al. A structural mechanism of integrin αIIbβ3 "inside-out" activation as regulated by its cytoplasmic face. Cell 2002, 110:587-597.
85. Ulmer T.S., Yaspan B., Ginsberg M.H., Campbell I.D. NMR analysis of structure and dynamics of the cytosolic tails of integrin alphaIIbbeta3 in aqueous solution. Biochemistry 2001, 40:7498-7508.
86. Vinogradova O., Vaynberg J., Kong X., Haas TA, Plow EF, Qin J Membrane-mediated structural transitions at the cytoplasmic face during integrin activation. Proc Natl Acad Sci USA 2004, 101:4094-4099.
87. Weljie A.M., Hwang P.M., Vogel H.J. Solution structures of the cytoplasmic tail complex from platelet integrin alpha IIb- and beta 3-subunits. Proc Natl Acad Sci USA 2002, 99:5878-5883.
88. Metcalf D.G., Moore D.T., Wu Y., Kielec JM, Molnar K, Valentine KG, et al. NMR analysis of the alphaIIb beta3 cytoplasmic interaction suggests a mechanism for integrin regulation. Proc Natl Acad Sci USA 2010, 107:22481-22486.
89. 3: a ternary complex of the integrin α and β subunits and a divalent cation. J Biol Chem 1996, 271:6017-6026.
90. Calderwood D.A., Fujioka Y., de Pereda J.M., Garcia-Alvarez B, Nakamoto T, Margolis B, et al. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci USA 2003, 100:2272-2277.
91. Beglova N., Blacklow S.C. The LDL receptor: how acid pulls the trigger. TIBS 2005, 30:309-317.
92. Uhlik M.T., Temple B., Bencharit S., Kimple AJ, Siderovski DP, Johnson GL Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J Mol Biol 2005, 345:1-20.
93. Li R., Babu C.R., Valentine K., Lear JD, Wand AJ, Bennett JS, et al. Characterization of the monomeric form of the transmembrane and cytoplasmic domains of the integrin beta 3 subunit by NMR spectroscopy. Biochemistry 2002, 41:15618-15624.
94. Ruoslahti E. Integrins. J Clin Invest 1991, 87:1-5.
95. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Biol 1996, 12:697-715.
96. 3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. J Biol Chem 1992, 267:5070-5077.
97. Cheresh D.A., Berliner S.A., Vicente V., Ruggeri Z.M. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989, 58:945-953.
98. 1 on endothelial cells. J Biol Chem 1997, 272:5360-5366.
99. Farrell D.H., Thiagarajan P., Chung D.W., Davie E.W. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992, 89:10729-10732.
100. Beacham D.A., Wise R.J., Turci S.M., Handin R.I. Selective inactivation of the arg-gly-asp-ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis. J Biol Chem 1992, 267:3409-3415.
101. 3 and elicit different functional responses. J Biol Chem 1999, 274:16923-16932.
102. Kloczewiak M., Timmons S., Hawiger J. Recognition site for the platelet receptor is present on the 15-residue carboxy-terminal fragment of the gamma chain of human fibrinogen and is not involved in the fibrin polymerization reaction. Thromb Res 1983, 29:249-255.
103. Plow E.F., Marguerie G.A., Ginsberg M. Fibrinogen, fibrinogen receptors and the peptides that inhibit these interactions. Biochem Pharmacol 1987, 36:4035-4040.
104. Tranqui L., Andrieux A., Hudry-Clergeon G., Ryckwaert J-J, Soyez S, Chapel A, et al. Differential structural requirements for fibrinogen binding to platelets and to endothelial cells. J Cell Biol 1989, 108:2519-2527.
105. Gartner T.K., Bennett J.S. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 1985, 260:11891-11894.
106. Plow E.F., Pierschbacher M.D., Ruoslahti E., Marguerie G.A., Ginsberg M.H. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 1985, 82:8057-8061.
107. 3. EMBO J 1996, 15:5760-5771.
108. Farrell D.H., Thiagarajan P. Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 1994, 269:226-231.
109. Smith R.A., Mosesson M.W., Rooney M.M., Lord ST, Daniels AU, Gartner TK The role of putative fibrinogen Aα-, Bβ-, and gammaA-chain integrin binding sites in endothelial cell-mediated clot retraction. J Biol Chem 1997, 272:22080-22085.
110. Mustard J.F., Packham M.A., Kinlough-Rathbone R.L., Perry D.W., Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood 1978, 52:453-465.
111. Marguerie G.A., Edgington T.S., Plow E.F. Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem 1980, 255:154-161.
112. Bennett J.S., Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979, 64:1393-1401.
113. Raborn J., Wang W., Luo B.H. Regulation of integrin alphaIIbbeta3 ligand binding and signaling by the metal ion binding sites in the beta I domain. Biochemistry 2011, 50:2084-2091.
114. Calvete J.J. Structures of integrin domains and concerted conformtional changes in the bidirectional signaling mechanism of alphaIIbbeta3. Exp Biol Med 2004, 229:732-744.
115. Takagi J., DeBottis D.P., Erickson H.P., Springer T.A. The role of the specificity-determining loop of the integrin beta subunit I-like domain in autonomous expression, association with the alpha subunit, and ligand binding. Biochemistry 2002, 41:4339-4347.
116. Shimaoka M., Takagi J., Springer T.A. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 2002, 31:485-516.
117. Luo B.H., Takagi J., Springer T.A. Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfides. J Biol Chem 2004, 279:10215-10221.
118. Luo B.H., Carman C.V., Springer T.A. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007, 25:619-647.
119. Wang W., Jiang Y., Wang C., Luo B.H. Effects of the association between the alpha-subunit thigh and the beta-subunit EGF2 domains on integrin activation and signaling. Biochemistry 2011, 50:9264-9272.
120. Kamata T., Handa M., Ito S., Sato Y., Ohtani T., Kawai Y., et al. Structural requirements for activation in alphaIIb beta3 integrin. J Biol Chem 2010, 285:38428-38437.
121. Adair B.D., Xiong J.P., Maddock C., Goodman S.L., Arnaout M.A., Yeager M. Three-dimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectin. J Cell Biol 2005, 168:1109-1118.
122. 3. J Cell Biol 1998, 141:1685-1695.
123. Buensucesco C., de Virgilio M., Shattil S.J. Detection of integrin alpha IIbbeta 3 clustering in living cells. J Biol Chem 2003, 278:15217-15224.
124. Carman C.V., Springer T.A. Integrin avidity regulation: are changes in affinity and conformation underemphasized?. Curr Opin Cell Biol 2003, 15:547-556.
125. Banno A., Ginsberg M.H. Integrin activation. Biochem Soc Trans 2008, 36:229-234.
126. Bunch T.A. Integrin alphaIIbbeta3 activation in Chinese hamster ovary cells and platelets increases clustering rather than affinity. J Biol Chem 2010, 285:1841-1849.
127. Ginsberg M.H., Du X., Plow E.F. Inside-out integrin signaling. Curr Opin Cell Biol 1992, 4:766.
128. O'Toole T.E., Katagiri Y., Faull R.J., Peter K., Tamura R., Quaranta V., et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994, 124:1047-1059.
129. Schwartz M.A., Schaller M.D., Ginsberg M.H. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Biol 1995, 11:549-599.
130. Shattil S.J., Ginsberg M.H., Brugge J.S. Adhesive signaling in platelets. Curr Opin Cell Biol 1994, 6:695-704.
131. Clark E.A., Brugge J.S. Integrins and signal transduction pathways: the road taken. Science 1995, 268:233-239.
132. Frelinger A.L., Lam S.C.T., Plow E.F., Smith MA, Loftus JC, Ginsberg MH Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem 1988, 263:12397-12402.
133. Parise L.V., Helgerson S.L., Steiner B., Nannizzi L., Phillips D.R. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa. J Biol Chem 1987, 262:12597-12602.
134. Dedhar S., Hannigan G.E. Integrin cytoplasmic interactions and bidirectional transmembrane signalling. Curr Opin Cell Biol. 1996, 8:657-669.
135. Packham M.A., Guccione M.A., Greenberg J.P., Kinlough-Rathbone R.L. Mustard JF. Release of 14C-serotonin during initial platelet changes induced by thrombin, collagen, or A23187. Blood 1977, 50:915-926.
136. Moroi M., Jung S.M. Platelet glycoprotein VI: its structure and function. Thromb Res. 2004, 114:221-233.
137. Nieswandt B., Watson S.P. Platelet-collagen interaction: is GPVI the central receptor?. Blood 2003, 102:449-461.
138. Poole A., Gibbins J.M., Turner M., van Vugt MJ, van de Winkel JG, Saito T, et al. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 1997, 16:2333-2341.
139. Asazuma N., Wilde J.I., Berlanga O., Leduc M, Leo A, Schweighoffer E, et al. Interaction of linker for activation of T cells with multiple adapter proteins in platelets activated by the glycoprotein VI-selective ligand, convulxin. J Biol Chem 2000, 275:33427-33434.
140. Falet H., Barkalow K.L., Pivniouk V.I., Barnes MJ, Geha RS, Hartwig JH Roles of SLP-76, phosphoinositide 3-kinase, and gelsolin in the platelet shape changes initiated by the collagen receptor GPVI/FcR gamma-chain complex. Blood 2000, 96:3786-3792.
141. Watson S.P., Auger J.M., McCarty O.J., Pearce A.C. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 2005, 3:1752-1762.
142. Li Z., Delaney M.K., O'Brien K.A., Du X. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010, 30:2341-2349.
143. Zheng Y.M., Liu C., Chen H., Locke D., Ryan J.C., Kahn M.L. Expression of the platelet receptor GPVI confers signaling via the Fc receptor gamma-chain in response to the snake venom convulxin but not to collagen. J Biol Chem 2001, 276:12999-13006.
144. Nieuwenhuis H.K., Akkerman J.W.N., Houdijk W.P.M., Sixma J.J. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985, 318:470-472.
145. Holtkotter O., Nieswandt B., Smyth N., Muller W., Hafner M., Schulte V., et al. Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 2002, 277:10789-10794.
146. Kroll M.H., Hellums J.D., McIntire L.V., Schafer A.I., Moake J.L. Platelets and shear stress. Blood 1996, 88:1525-1541.
147. Andrews R.K., Kroll M.H., Ward C.M., Rose J.W., Scarborough R.M., Smith A.I., et al. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 1996, 35:12629-12639.
148. Feng S., Christodoulides N., Resendiz J.C., Berndt M.C., Kroll M.H. Cytoplasmic domains of GpIbalpha and GpIbbeta regulate 14-3-3zeta binding to GpIb/IX/V. Blood 2000, 95:551-557.
149. Gu M., Xi X., Englund G.D., Berndt M.C., Du X. Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model. J Cell Biol 1999, 147:1085-1096.
150. Zaffran Y., Meyer S.C., Negrescu E., Reddy K.B., Fox J.E. Signaling across the platelet adhesion receptor glycoprotein Ib-IX induces alpha IIbbeta 3 activation both in platelets and a transfected Chinese hamster ovary cell system. J Biol Chem 2000, 275:16779-16787.
151. Chen J., Lopez J.A. Interactions of platelets with subendothelium and endothelium. Microcirculation 2005, 12:235-246.
152. Xi X., Bodnar R.J., Li Z., Lam S.C., Du X. Critical roles for the COOH-terminal NITY and RGT sequences of the integrin beta3 cytoplasmic domain in inside-out and outside-in signaling. J Cell Biol 2003, 162:329-339.
153. Kahn M.L., Zheng Y.W., Huang W., Bigornia V., Zeng D., Moff S., et al. A dual thrombin receptor system for platelet activation. Nature 1998, 394:690-694.
154. Coughlin S.R. Thrombin signalling and protease-activated receptors. Nature 2000, 407:258-264.
155. Vu T.K., Wheaton V.I., Hung D.T., Charo I., Coughlin S.R. Domains specifying thrombin-receptor interaction. Nature 1991, 353:674-677.
156. Sambrano G.R., Weiss E.J., Zheng Y.W., Huang W., Coughlin S.R. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 2001, 413:74-78.
157. Watanabe N., Bodin L., Pandey M., Krause M., Coughlin S., Boussiotis V.A., et al. Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3. J Cell Biol 2008, 181:1211-1222.
158. Hollopeter G., Jantzen H.M., Vincent D., Li G., England L., Ramakrishnan V., et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001, 409:202-207.
159. Fabre J.E., Nguyen M., Latour A., Keifer J.A., Audoly L.P., Coffman T.M., et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999, 5:1199-1202.
160. MacKenzie A.B., Mahaut-Smith M.P., Sage S.O. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. J Biol Chem 1996, 271:2879-2881.
161. Kunapuli S.P. Molecular physiology of platelet ADP receptors. Drug Dev Res 1998, 45:135-139.
162. Dorsam R.T., Kunapuli S.P. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004, 113:340-345.
163. Hirata T., Ushikubi F., Kakizuka A., Okuma M., Narumiya S. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 1996, 97:949-956.
164. Marguerie G.A., Plow E.F. The fibrinogen dependent pathway of platelet aggregation. Ann NY Acad Sci 1983, 408:556-567.
165. Abrams C.S. Intracellular signaling in platelets. Curr Opin Hematol 2005, 12:401-405.
166. Fox J.E.B., Reynolds C.C., Phillips D.R. Calcium-dependent proteolysis occurs during platelet aggregation. J Biol Chem 1983, 258:9973-9981.
167. Saido T.C., Shibata M., Takenawa T., Murofushi H., Suzuki K. Positive regulation of μ-calpain action by polyphosphoinositides. J Biol Chem 1992, 267:24585-24590.
168. Tsujinaka T., Sakon M., Kambayashi J., Kosaki G. Cleavage of cytoskeletal proteins by two forms of Ca2+ activated neutral proteases in human platelets. Thromb Res 1982, 28:149-156.
169. Suzuki K., Imajoh S., Emori Y., Kawasaki H., Minami Y., Ohno S. Calcium-activated neutral protease and its endogenous inhibitor. Activation at the cell membrane and biological function. FEBS Lett 1987, 220:271-277.
170. Kawasaki H., Springett G.M., Toki S., Canales J.J., Harlan P., Blumenstiel J.P., et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci USA 1998, 95:13278-13283.
171. Dupuy A.J., Morgan K., von Lintig F.C., Shen H., Acar H., Hasz D.E., et al. Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia. J Biol Chem 2001, 276:11804-11811.
172. Crittenden J.R., Bergmeier W., Zhang Y., Piffath C.L., Liang Y., Wagner D.D., et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004, 10:982-986.
173. Chrzanowska-Wodnicka M., Smyth S.S., Schoenwaelder S.M., Fischer T.H., White G.C. Rap1b is required for normal platelet function and hemostasis in mice. J Clin Invest 2005, 115:680-687.
174. Stefanini L., Bergmeier W. CalDAG-GEFI and platelet activation. Platelets 2010, 21:239-243.
175. Chen J., De S., Damron D.S., Chen W.S., Hay N., Byzova T.V. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 2004, 104:1703-1710.
176. Woulfe D., Jiang H., Mortensen R., Yang J., Brass L.F. Activation of Rap1B by G(i) family members in platelets. J Biol Chem 2002, 277:23382-23390.
177. Lee H.S., Lim C.J., Puzon-McLaughlin W., Shattil S.J., Ginsberg M.H. RIAM activates integrins by linking talin to ras GTPase >membrane-targeting sequences. J Biol Chem 2009, 284:5119-5127.
178. Sastry S.K., Horwitz A.F. Integrin cytoplasmic domains: mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling. Curr Opin Cell Biol 1993, 5:819-831.
179. Parise L.V., Criss A.B., Nannizzi L., Wardell M.R. Glycoprotein IIIa is phosphorylated in intact human platelets. Blood 1990, 75:2363-2368.
180. Phillips D.R., Nannizzi-Alaimo L., Prasad K.S. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost 2001, 86:246-258.
181. Phillips D.R., Prasad K.S., Manganello J., Bao M., Nannizzi-Alaimo L. Integrin tyrosine phosphorylation in platelet signaling. Curr Opin Cell Biol 2001, 13:546-554.
182. Qin J., Vinogradova O., Plow E.F. Integrin bidirectional signaling: a molecular view. PLoS Biol 2004, 2:726-729.
183. Legate K.R., Fassler R. Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails. J Cell Sci 2009, 122:187-198.
184. IIIb. Science 1991, 254:845-847.
185. Hughes P.E., O'Toole T.E., Ylanne J., Shattil S.J., Ginsberg M.H. The conserved membrane-proximal region of an integrin cytoplasmic domain specifies ligand binding affinity. J Biol Chem 1995, 270:12411-12417.
186. Ma Y.Q., Yang J., Pesho M.M., Vinogradova O., Qin J., Plow E.F. Regulation of integrin alpha(IIb)beta(3) activation by distinct regions of its cytoplasmic tails. Biochemistry 2006, 45:6656-6662.
187. Haas T.A., Plow E.F. Development of a structural model for the cytoplasmic domain of an integrin. Protein Eng 1997, 10:1395-1405.
188. Hughes P.E., Diaz-Gonzalez F., Leong L., Wu C., McDonald J.A., Shattil S.J., et al. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J Biol Chem 1996, 271:6571-6574.
189. Kim M., Carman C.V., Springer T.A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 2003, 301:1720-1725.
190. Lu C., Takagi J., Springer T.A. Association of the membrane proximal regions of the α and β subunit cytoplasmic domains constrains an integrin in the inactive state. J Biol Chem 2001, 276:14642-14648.
191. Yang J, Ma YQ, Page RC, Misra S, Plow EF, Qin J. Structure of an integrin alphaIIbbeta3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation. Proc Natl Acad Sci USA 2009;17729-34.
192. Litvinov R.I., Nagaswami C., Vilaire G., Shuman H., Bennett J.S., Weisel J.W. Functional and structural correlations of individual alphaIIbbeta3 molecules. Blood 2004, 104:3979-3985.
193. Critchley D.R., Gingras A.R. Talin at a glance. J Cell Sci 2008, 121:1345-1347.
194. Rees D.J., Ades S.E., Singer S.J., Hynes R.O. Sequence and domain structure of talin. Nature 1990, 347:685-689.
195. Burridge K., Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 1996, 12:463-518.
196. 1 integrin subunit in vitro. J Cell Biol 1990, 11:721-729.
197. Priddle H., Hemmings L., Monkley S., Woods A., Patel B., Sutton D., et al. Disruption of the talin gene compromises focal adhesion assembly in undifferentiated but not differentiated embryonic stem cells. J Cell Biol 1998, 142:1121-1133.
198. Monkley S.J., Zhou X.H., Kinston S.J., Giblett S.M., Hemmings L., Priddle H., et al. Disruption of the talin gene arrests mouse development at the gastrulation stage. Dev Dyn 2000, 219:560-574.
199. Pearson M.A., Reczek D., Bretscher A., Karplus P.A. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 2000, 101:259-270.
200. Garcia-Alvarez B., de Pereda J.M., Calderwood D.A., Ulmer T.S., Critchley D., Campbell I.D., et al. Structural determinants of integrin recognition by talin. Mol Cell 2003, 11:49-58.
201. Calderwood D.A., Zent R., Grant R., Rees D.J., Hynes R.O., Ginsberg M.H. The talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 1999, 274:28071-28074.
202. Calderwood D.A., Yan B., de Pereda J.M., Garcia-Alvarez B., Fujioka Y., Liddington R.C., et al. The phosphotyrosine binding (PTB)-like domain of talin activates integrins. J Biol.Chem 2002, 277:21749-21758.
203. Tadokoro S., Shattil S.J., Eto K., Tai V., Liddington R.C., De Pereda J.M., et al. Talin binding to integrin β tails: a final common step in integrin activation. Science 2003, 302:103-106.
204. Ulmer T.S., Calderwood D.A., Ginsberg M.H., Campbell I.D. Domain-specific interactions of talin with the membrane-proximal region of the integrin beta3 subunit. Biochemistry 2003, 42:8307-8312.
205. Wegener K.L., Partridge A.W., Han J., Pickford A.R., Liddington R.C., Ginsberg M.H., et al. Structural basis of integrin activation by talin. Cell 2007, 128:171-182.
206. Bouaouina M., Lad Y., Calderwood D.A. The N-terminal domains of talin cooperate with the phosphotyrosine binding-like domain to activate beta1 and beta3 integrins. J Biol Chem 2008, 283:6118-6125.
207. Xing B., Jedsadayanmata A., Lam S.C. Localization of an integrin binding site to the C terminus of talin. J Biol Chem 2001, 276:44373-44378.
208. Gingras A.R., Ziegler W.H., Bobkov A.A., Joyce M.G., Fasci D., Himmel M., et al. Structural determinants of integrin binding to the talin rod. J Biol Chem 2009, 284:8866-8876.
209. Yan B., Calderwood D.A., Yaspan B., Ginsberg M.H. Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain. J Biol Chem 2001, 276:28164-28170.
210. 3. J Biol Chem 1996, 271:16416-16421.
211. Patil S., Jedsadayanmata A., Wencel-Drake J.D., Wang W., Knezevic I., Lam S.C. Identification of a talin-binding site in the integrin beta(3) subunit distinct from the NPLY regulatory motif of post-ligand binding functions. The talin n-terminal head domain interacts with the membrane- proximal region of the beta(3) cytoplasmic tail. J Biol Chem 1999, 274:28575-28583.
212. Ma Y.Q., Qin J., Wu C., Plow E.F. Kindlin-2 (Mig-2): a co-activator of beta3 integrins. J Cell Biol 2008, 181:439-446.
213. Ye Hu G, Taylor D., Ratnikov B., Bobkov A.A., McLane M.A., et al. Recreation of the terminal events in physiological integrin activation. J Cell Biol 2010, 188(1):157-173.
214. Goksoy E., Ma Y.-Q., Wang X., Kong X., Perera D., Plow E.F., et al. Structural basis for the autoinhibition of talin in regulating integrin activation. Mol Cell 2008, 31:124-133.
215. Goult B.T., Bate N., Anthis N.J., Wegener K.L., Gingras AR., Patel B., et al. The structure of an interdomain complex that regulates talin activity. J Biol Chem 2009, 284:15097-15106.
216. Han J., Lim C.J., Watanabe N., Soriani A., Ratnikov B., Calderwood D.A., et al. Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol 2006, 16:1796-1806.
217. Martel V., Racaud-Sultan C., Dupe S., Marie C., Paulhe F., Galmiche A., et al. Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides. J Biol Chem 2001, 276:21217-21227.
218. Inomata M., Hayashi M., Ohno-Iwashita Y., Tsubuki S., Saido T.C., Kawashima S. Involvement of calpain in integrin-mediated signal transduction. Arch Biochem Biophys 1996, 328:129-134.
219. Hayashi M., Suzuki H., Kawashima S., Saido T.C., Inomata M. The behavior of calpain-generated N- and C-terminal fragments of talin in integrin-mediated signaling pathways. Arch Biochem Biophys 1999, 371:133-141.
220. Shattil S.J., Kim C., Ginsberg M.H. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010, 11:288-300.
221. D'Souza M.A., Kimble R.M., McMillan J.R. Kindler syndrome pathogenesis and fermitin family homologue 1 (kindlin-1) function. Dermatol. Clin 2010, 28:115-118.
222. Moser M., Legate K.R., Zent R., Fassler R. The tail of integrins, talin, and kindlins. Science 2009, 324:895-899.
223. Montanez E., Ussar S., Schifferer M., Bosl M., Zent R., Moser M., et al. Kindlin-2 controls bidirectional signaling of integrins. Genes Dev 2008, 22:1325-1330.
224. Dowling J.J., Gibbs E., Russell M., Goldman D., Minarcik J., Golden J.A., et al. Kindlin-2 Is an essential component of intercalated discs and is required for vertebrate cardiac structure and function. Circ. Res 2008, 102:423-431.
225. Pluskota E., Dowling J.J., Gordon N., Golden J.A., Szpak D., West X.Z., et al. The integrin coactivator kindlin-2 plays a critical role in angiogenesis in mice and zebrafish. Blood 2011, 117:4978-4987.
226. Ussar S., Wang H.V., Linder S., Fassler R., Moser M. The kindlins: subcellular localization and expression during murine development. Exp Cell Res 2006, 312:3142-3151.
227. Bialkowska K., Ma Y.Q., Bledzka K., Sossey-Alaoui K., Izem L., Zhang X., et al. The integrin coactivator kindlin-3 is expressed and functional in a non-hematopoietic cell, the endothelial cell. J Biol Chem 2010, 285:18640-18649.
228. Moser M., Nieswandt B., Ussar S., Pozgajova M., Fassler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 2008, 14:325-330.
229. Svensson L., Howarth K., McDowall A., Patzak I., Evans R., Ussar S., et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 2009, 15:306-312.
230. Malinin N.L., Zhang L., Choi J., Ciocea A., Razorenova O., Ma Y.-Q., et al. A point mutation in kindlin-3 ablates activation of three integrin subfamilies in humans. Nat Med 2009, 15:313-318.
231. Shi X., Ma Y.Q., Tu Y., Chen K., Wu S., Fukuda K., et al. The mitogen inducible gene-2 (Mig-2)-integrin interaction strengthens cell-matrix adhesion and modulates cell motility. J Biol Chem 2007, 282:20455-20466.
232. Plow E.F., Qin J., Byzova T. Kindling the flame of integrin activation and function with kindlins. Curr Opin Hematol 2009, 16:323-328.
233. Qu H., Tu Y., Shi X., Larjava H., Saleem M.A., Shattil S.J., et al. Kindlin-2 regulates podocyte adhesion and fibronectin matrix deposition through interactions with phosphoinositides and integrins. J Cell Sci 2011, 124:879-891.
234. Larjava H., Plow E.F., Wu C. Kindlins: essential regulators of integrin signalling and cell-matrix adhesion. EMBO Rep 2008, 9:1203-1208.
235. Meves A., Stremmel C., Gottschalk K., Fassler R. The Kindlin protein family: new members to the club of focal adhesion proteins. Trends Cell Biol 2009, 19:504-513.
236. Malinin N.L., Plow E.F., Byzova T.V. Kindlins in FERM adhesion. Blood 2010, 115:4011-4017.
237. Kiema T., Lad Y., Jiang P., Oxley C.L., Baldassarre M., Wegener K.L., et al. The molecular basis of filamin binding to integrins and competition with talin. Mol Cell 2006, 21:337-347.
238. Bouvard D., Millon-Fremillon A., Dupe-Manet S., Block M.R., Albiges-Rizo C. Unraveling ICAP-1 function: toward a new direction?. Eur J Cell Biol 2006, 85:275-282.
239. Chang D.D., Wong C., Smith H., Liu J. ICAP-1, a novel beta1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of beta1 integrin. J Cell Biol 1997, 138:1149-1157.
240. Ithychanda S.S., Hsu D., Li H., Yan L., Liu D.D., Das M., et al. Identification and characterization of multiple similar ligand-binding repeats in filamin: implication on filamin-mediated receptor clustering and cross-talk. J Biol Chem 2009, 284:35113-35121.
241. Brunner M., Millon-Fremillon A., Chevalier G., Nakchbandi IA, Mosher D, Block MR, et al. Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition. J Cell Biol 2011, 194:307-322.
242. Shock D.D., Naik U.P., Brittain J.E., Alahari S.K., Sondek J., Parise L.V., et al. Calcium-dependent properties of CIB binding to the integrin αIIb cytoplasmic domain and translocation to the platelet cytoskeleton. Biochem J 1999, 342:729-735.
243. IIb cytoplasmic domain. J Biol Chem 1997, 272:4651-4654.
244. Barry W.T., Boudignon-Proudhon C., Shock D.D., McFadden A., Weiss J.M., Sondek J., et al. Molecular basis of CIB binding to the integrin alpha IIb cytoplasmic domain. J Biol Chem 2002, 277:28877-28883.
245. Larkin D., Murphy D., Reilly D.F., et al. ICln, a novel integrin alphaIIbbeta3-associated protein, functionally regulates platelet activation. J Biol Chem 2004, 279:27286-27293.
246. Kato A., Kawamata N., Tamayose K., et al. Ancient ubiquitous protein 1 binds to the conserved membrane-proximal sequence of the cytoplasmic tail of the integrin alpha subunits that plays a crucial role in the inside-out signaling of alpha IIbbeta 3. J Biol Chem 2002, 277:28934-28941.
247. Vijayan K.V., Liu Y., Li T.T., Bray P.F. Protein phosphatase 1 associates with the integrin alphaIIb subunit and regulates signaling. J Biol Chem 2004, 279:33039-33042.
248. Rantala J.K., Pouwels J., Pellinen T., Veltel S., Laasola P., Mattila E., et al. SHARPIN is an endogenous inhibitor of beta1-integrin activation. Nat Cell Biol 2011, 13:1315-1324.
249. Tu Y., Wu S., Shi X., Chen K., Wu C. Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell 2003, 113:37-47.
250. Wu C. Migfilin and its binding partners: from cell biology to human diseases. J Cell Sci 2005, 118:659-664.
251. Ithychanda S.S., Das M., Ma Y.Q., Ding K., Wang X., Gupta S., et al. Migfilin, a molecular switch in regulation of integrin activation. J Biol Chem 2009, 284:4713-4722.
252. Lad Y., Jiang P., Ruskamo S., et al. Structural basis of the migfilin-filamin interaction and competition with integrin beta tails. J Biol Chem 2008, 283:35154-35163.
253. Brown E., Hooper L., Ho T., Gresham H. Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 1990, 111:2785-2794.
254. Zent R., Fenczik C.A., Calderwood D.A., Liu S., Dellos M., Ginsberg M.H. Class- and splice variant-specific association of CD98 with integrin beta cytoplasmic domains. J Biol Chem 2000, 275:5059-5064.
255. Dorahy D.J., Berndt M.C., Shafren D.R., Burns G.F. CD36 is spatially associated with glycoprotein IIb-IIIa (alpha IIb beta 3) on the surface of resting platelets. Biochem Biophys Res Commun 1996, 218:575-581.
256. Slupsky J.R., Seehafer J.G., Tang S.C., Masellis-Smith A., Shaw A.R. Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. J Biol Chem 1989, 264:12289-12293.
257. Israels S.J., Millan-Ward E.M., Easton J., Robertson C., McNicol A. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets. Thromb Haemost 2001, 85:134-141.
258. 3 integrins in haemopoietic cell lines and modulates cell-cell adhesion. Biochem J 1999, 338:61-70.
259. Chung J., Gao A.G., Frazier W.A. Thrombospondin acts via integrin-associated protein to activate the platelet integrin αIIbβ3. J Biol Chem 1997, 272:14740-14746.
260. Dorahy D.J., Thorne R.F., Fecondo J.V., Burns G.F. Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor. J Biol Chem 1997, 272:1323-1330.
261. Frazier W.A., Gao A.G., Dimitry J., Chung J., Brown E.J., Lindberg F.P., et al. The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J Biol Chem 1999, 274:8554-8560.
262. Fenczik C.A., Sethi T., Ramos J.W., Hughes P.E., Ginsberg M.H. Complementation of dominant suppression implicates CD98 in integrin activation. Nature 1997, 390:81-85.
263. Huang M.M., Bolen J.B., Barnwell J.W., Shattil S.J., Brugge J.S. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA 1991, 88:7844-7848.
264. Aiken M.L., Ginsberg M.H., Byers-Ward V., Plow E.F. Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood 1990, 76:2501-2509.
265. Leung L.L.K. Role of thrombospondin in platelet aggregation. J Clin Invest 1984, 74:1764-1772.
266. Lau L.M., Wee J.L., Wright M.D., Moseley G.W., Hogarth P.M., Ashman L.K., et al. The tetraspanin superfamily member CD151 regulates outside-in integrin alphaIIbbeta3 signaling and platelet function. Blood 2004, 104:2368-2375.
267. Armulik A., Nilsson I., von Heijne G., Johansson S. Determination of the border between the transmembrane and cytoplasmic domains of human integrin subunits. J Biol Chem 1999, 274:37030-37034.
268. Qin J., Vinogradova O., Plow E.F. Integrin bidirectional signaling: a molecular view. PLoS Biol 2004, 2:e169.
269. Kalli A.C., Wegener K.L., Goult B.T., Anthis N.J., Campbell I.D., Sansom M.S. The structure of the talin/integrin complex at a lipid bilayer: an NMR and MD simulation study. Structure 2010, 18:1280-1288.